Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat

por Frey, Reiner, Lettieri, John, Nadel, Andrea, Becker, Corina, Mück, Wolfgang
Publicado 2013

No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects

por Huang, Funan, Ajavon, Antoinette, Huang, Erya, Lettieri, John, Liu, Rong, Peña, Carol, Berse, Matthias
Publicado 2017

Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects

por Gerisch, Michael, Hafner, Frank-Thorsten, Lang, Dieter, Radtke, Martin, Diefenbach, Konstanze, Cleton, Adriaan, Lettieri, John
Publicado 2017

Exposure–Response Modeling and Simulation of Progression‐Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer

por Grevel, Joachim, Jentsch, Garrit, Austin, Rupert, Prins, Nicolaas H., Lettieri, John, Mitchell, David, Huang, Funan, Brose, Marcia S., Schlumberger, Martin, Meinhardt, Gerold, Peña, Carol E. A., Ploeger, Bart A.
Publicado 2019